🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are urged to contact these accounts directly for source information, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where communities with numerous of participants share “before and after” photos, administration instructions and assertions of rapid British shipping. Vendors market the drug there before directing buyers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Experts Express Concerns

However, doctors and chemists have cautions that the sale of what remains an unlicensed medication in the UK is worrisome and could lead to users injecting products of unknown origin.

Some professionals stated the popularity for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.

Several content creators attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still violate medicines, marketing, and consumer laws, potentially leading to fines, prosecution or prison.

Platform Response and Content Removal

Based on TikTok, the service has removed problematic content and prohibited related keywords and search suggestions. The company said it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.

Digital Trading Operations

Research also discovered groups with up to nine thousand members marketing the experimental drug using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, filled with images of slimming results, positive reviews and step-by-step guides for preparing or administering at home.

Within minutes of entering one community, a vendor shared WhatsApp details, where most purchases occur. The vendor sent an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one asked about body mass, health issues or previous experience.

Item Information and Costs

Within these groups, messages show dark colored parcels with Royal Mail labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give conflicting responses varying between a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for Telegram said it actively moderated dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering materials they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are using online platforms. But fake injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has previously seen patients injured by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from Telegram or communication platforms is taking chances with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company experimental substance not yet approved … may subject users to possibly serious health risks”.